Acrux moves into new lab facilities
Friday, 18 October, 2002
Acrux has officially opened its new facilities in West Melbourne, kicking off a new phase in the company's growth.
Company chairman Maurice Newman said the move was a defining moment in Acrux's process of going from start-up company to serious biotechnology organisation. "Acrux is an important company, and it's a good news story for Victoria and Australia," he said.
The new facility contains both office and laboratory space. It allows Acrux to accelerate into late-stage development of three products: fentanyl for the treatment of chronic pain, estradiol for management of post-menopausal symptoms and testosterone for certain types of female sexual dysfunction as well as continue with other projects, including its collaboration with pharmaceutical company Pharmacia.
Until now, the company has been incubated at the Victorian College of Pharmacy at Monash University, where the technology was first developed.
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
